Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Repair of Subscapularis Tear :Clinical Results and MRI Analysis

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2012 by Peking University Third Hospital
Sponsor:
Information provided by (Responsible Party):
Lin Lin, Peking University Third Hospital
ClinicalTrials.gov Identifier:
NCT01752088
First received: December 14, 2012
Last updated: December 18, 2012
Last verified: June 2012
  Purpose

This study is to evaluate the magnetic resonance imaging (MRI) and clinical results of arthroscopic repair of subscapularis tears


Condition
Rupture Subscapularis Tendon

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Target Follow-Up Duration: 2 Years
Official Title: Arthroscopic Repair of Subscapularis Tear :Clinical Results and MRI Analysis

Further study details as provided by Peking University Third Hospital:

Primary Outcome Measures:
  • Clinical results and MRI analysis [ Time Frame: 2 year ] [ Designated as safety issue: No ]
    ROM UCLA Constant ASES VAS MRI


Estimated Enrollment: 60
Study Start Date: June 2012
Estimated Study Completion Date: December 2014
Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
Detailed Description:

ROM UCLA Constant ASES VAS MRI Goutallier

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patients suffering from rotator cuff injury will be scheduled for an arthroscopic procedure

Criteria

Inclusion Criteria:

- Patients suffering from rotator cuff injury scheduled for an arthroscopic procedure. A partial- or full-thickness subscapu-laris tendon tear

Exclusion Criteria:

- revision repairs or open repairs.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01752088

Contacts
Contact: Lin Lin, MD. PhD 86-10-82267019 simon.lin2003@163.com

Locations
China, Beijing
Peking University Third Hospital Recruiting
Beijing, Beijing, China, 100191
Contact: lin lin, MD, PhD    86-10-82267019    simon.lin2003@163.com   
Principal Investigator: lin lin, MD, PhD         
Sponsors and Collaborators
Peking University Third Hospital
Investigators
Study Chair: Guoqing Cui, MD Peking University Third Hospital
  More Information

Publications:
Responsible Party: Lin Lin, Dr., Peking University Third Hospital
ClinicalTrials.gov Identifier: NCT01752088     History of Changes
Other Study ID Numbers: SSC2012
Study First Received: December 14, 2012
Last Updated: December 18, 2012
Health Authority: China: Food and Drug Administration

Keywords provided by Peking University Third Hospital:
apularis, MRI clinical, results

ClinicalTrials.gov processed this record on November 24, 2014